Diffuse Hair Loss in Women
May 2002
in “
Therapeutische Umschau
”
TLDR The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.
In 2002, the document addressed diffuse hair loss in women, particularly androgenetic alopecia (AGA) and chronic telogen effluvium (CTE). It highlighted the effectiveness of cyproterone acetate (CPA) in treating AGA, with varying success rates, and noted that low-dose oral CPA combined with ethinyl estradiol improved AGA in 84% of cases. For CTE, the document emphasized the importance of reassurance and viewing the condition as increased hair shedding rather than hair loss. Minoxidil was reported to be 63% effective in a study of 256 women for treating AGA. The document also mentioned other treatments like estrogens and nutritional supplements, but their effectiveness was not well-supported by controlled studies. The need for a trusting doctor-patient relationship and empathy was stressed to help patients cope with their condition.
